Letter by Zito et al Regarding Article, "Warfarin Versus Aspirin for Prevention of Cognitive Decline in Atrial Fibrillation: Randomized Controlled Trial (Birmingham Atrial Fibrillation Treatment of the Aged Study)"

被引：0
|
作者：
Zito, Stefano [1 ]
Lattanzio, Francesco [1 ]
Di Nisio, Marcello [2 ]
机构：
[1] Univ G DAnnunzio Fdn, Internal Med Unit, Ctr Aging Sci, Dept Med & Aging, Chieti, Italy
[2] Univ G dAnnunzio, Dept Med Oral & Biotechnol Sci, Chieti, Italy
来源：
STROKE | 2014年 / 45卷 / 09期
关键词：
OLDER-ADULTS;
D O I：
10.1161/STROKEAHA.114.006267
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：E191 / E191
页数：1
相关论文
共 50 条
  • [21] PLACEBO-CONTROLLED, RANDOMIZED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL-FIBRILLATION
    PETERSEN, P
    BOYSEN, G
    GODTFREDSEN, J
    ANDERSEN, ED
    ANDERSEN, B
    LANCET, 1989, 1 (8631): : 175 - 179
  • [22] Letter by Gomez et al Regarding Article, "Colchicine Reduces Postoperative Atrial Fibrillation: Results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) Atrial Fibrillation Substudy"
    Gomez Mejia, Mabel Fernanda
    Buitrago Sandoval, Andres Felipe
    Diaz Acevedo, Jesus Hernando
    CIRCULATION, 2012, 125 (25) : E1053 - E1053
  • [23] Letter by Krisai et al Regarding Article, "Pulsed Field Ablation for the Treatment of Atrial Fibrillation: PULSED AF Pivotal Trial"
    Krisai, Philipp
    Kuehne, Michael
    Sticherling, Christian
    CIRCULATION, 2023, 148 (15) : 1182 - 1182
  • [24] Letter by Stollberger et al Regarding Article, "Stroke Risk and Antithrombotic Strategies in Atrial Fibrillation"
    Stoellberger, Claudia
    Schneider, Birke
    Finsterer, Josef
    STROKE, 2011, 42 (04) : E365 - E365
  • [25] Response to Letter Regarding Article, "Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation: A Report From the Swedish Atrial Fibrillation Cohort Study"
    Friberg, Leif
    Rosenqvist, Marten
    Lip, Gregory Y. H.
    CIRCULATION, 2012, 126 (20) : E323 - E323
  • [26] Randomized Prospective Trial of Percutaneous Left Atrial Appendage Closure versus Warfarin for Stroke Prevention in Atrial Fibrillation
    Grimm, W.
    HERZ, 2009, 34 (03) : 248 - 248
  • [27] Letter by Sposato et al Regarding Article, "Stroke as the Initial Manifestation of Atrial Fibrillation: The Framingham Heart Study"
    Sposato, Luciano A.
    Fridman, Sebastian
    Saposnik, Gustavo
    STROKE, 2017, 48 (06) : E142 - E142
  • [28] Letter by Freeman et al Regarding Article, "Intracranial Hemorrhage in Atrial Fibrillation Patients During Anticoagulation With Warfarin or Dabigatran: The RE-LY Trial"
    Freeman, W. David
    Kuo, Ruth
    Aguilar, Maria I.
    STROKE, 2012, 43 (07) : E63 - E63
  • [29] BAFTA study - Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation
    Buksinska-Lisik, Malgorzata
    KARDIOLOGIA POLSKA, 2007, 65 (11) : 1399 - 1402
  • [30] Response by Piccini et al to Letters Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation"
    Piccini, Jonathan P.
    Hellkamp, Anne S.
    Washam, Jeffrey B.
    Becker, Richard C.
    Breithardt, Guenter
    Berkowitz, Scott D.
    Halperin, Jonathan L.
    Hankey, Graeme J.
    Hacke, Werner
    Mahaffey, Kenneth W.
    Nessel, Christopher C.
    Singer, Daniel E.
    Fox, Keith A. A.
    Patel, Manesh R.
    CIRCULATION, 2016, 134 (02) : E7 - E8
12345